Management of Beta-Lactamase Positive Haemophilus influenzae Peritoneal Cavity Infections

First-Line Treatment Options

The American College of Physicians recommends amoxicillin-clavulanate as a first-line therapy for beta-lactamase positive Haemophilus influenzae peritoneal cavity infections, due to its high efficacy against beta-lactamase producing strains 1
Second-generation cephalosporins, such as cefuroxime, provide excellent coverage for beta-lactamase producing H. influenzae strains, with a recommended dose of 1.5g IV q8h 1
Fluoroquinolones, including ciprofloxacin, levofloxacin, and moxifloxacin, are effective alternatives for the treatment of beta-lactamase positive H. influenzae peritoneal cavity infections, with recommended doses of 400mg IV/PO q12h, 750mg IV/PO qd, and 400mg IV/PO qd, respectively 1, 2

Beta-lactamase production is the primary mechanism of resistance in Haemophilus species, rendering the organism resistant to aminopenicillins, such as ampicillin and amoxicillin, with a strength of evidence level of high 1

For moderate peritoneal cavity infections, the first choice of treatment is oral amoxicillin-clavulanate 625mg three times daily, with alternatives including oral fluoroquinolones, such as ciprofloxacin 500mg twice daily or levofloxacin 500mg once daily, and oral cefuroxime axetil 750mg twice daily 1, 2, 3, 4, 5
For severe peritoneal cavity infections, alternatives to first-line therapy include IV cefuroxime 1.5g three times daily or cefotaxime 1g three times daily, and IV fluoroquinolones, such as levofloxacin 500mg daily or ciprofloxacin 400mg twice daily, with a strength of evidence level of moderate 2, 3, 1

Clinical response should be assessed within 48-72 hours of initiating therapy, with consideration of alternative therapy if no improvement is observed after 72 hours, based on a strength of evidence level of high 1
For severe infections, monitoring inflammatory markers can help assess treatment response, with a recommended frequency of every 24-48 hours 1

Susceptibility testing is crucial, as some H. influenzae strains may have multiple resistance mechanisms beyond beta-lactamase production, with a strength of evidence level of high 1
In polymicrobial peritonitis, coverage for anaerobes, such as Bacteroides fragilis, and Enterobacteriaceae is essential, with a recommended regimen including metronidazole 500mg IV q8h and ceftriaxone 1g IV q24h 6